Volunteers and coordinators from the American Diabetes Association (ADA) recently paid a visit to Einstein to learn more about our ADA-funded research projects, in the hope of forming a better partnership between the Bronx community, researchers and ADA donors. Linda Sung, team leader at Ernst & Young and a volunteer in the ADA's "Step Out: Walk to Stop Diabetes," program was joined by Pamela Schwartz, walk director for New York City Step Out, and Kevin Shippy, executive director of ADA Greater New York Area, during the meeting with members of Einstein's Diabetes Research Center (DRC).
Members of the ADA group discussed the high prevalence of diabetes in the Bronx, as well as their experience at a recent Diabetes Expo held at the Javits Convention Center, where they learned how thousands of diabetes sufferers are medically underserved in the greater New York area. During a series of presentations by DRC members, Dr. Jeffrey Pessin, director of the DRC and the Judy R. and Alfred A. Rosenberg Chair in Diabetes Research, discussed the center's efforts to address underserved populations, its partnership with Mount Sinai's Diabetes Center and pilot grants available to young diabetes researchers.
The researchers then detailed some of the ADA-funded work at Einstein. To begin, Dr. Preeti Kishore, associate professor of clinical medicine, explained her work involving vitamin D deficiency and insulin resistance. She has found that supplementing vitamin D to normal levels in insulin-resistant study volunteers improves insulin sensitivity and decreases inflammation within fat tissue. Dr. Jill Crandall, professor of clinical medicine, then discussed her research investigating the benefits of resveratrol supplementation. She was followed by Dr. Meredith Hawkins, professor of medicine and holder of the Harold and Muriel Block Chair in Medicine, who described her studies of the role of the brain in altered liver glucose metabolism in diabetes patients.
The ADA visit ended with a tour of the Clinical Research Center, which is dedicated to patient-oriented research at Einstein. "Our visitors were very pleased to learn about the breadth of diabetes research being conducted at Einstein," noted Dr. Kishore. "And we were pleased to have the opportunity to demonstrate how their support is critically important to the work we do."
Drugs in America: Friend or Foe?
Wednesday, January 18, 2017
New Division Chief Appointed in Nephrology
Tuesday, January 10, 2017
Recognizing Service to Einstein
Wednesday, January 04, 2017
In Memoriam: David Hamerman, M.D., Among Einstein's Initial Faculty Members
Wednesday, December 28, 2016
Einstein Hosts Conference to Address Key Issues Common to Global Health Programs
Friday, December 23, 2016
Dr. Mark Greenberg Is This Year's Honoree at Annual Montefiore-Einstein Reception for UJA-Federation
Thursday, December 22, 2016
Job-Hunting Advice for Postdocs
Monday, December 19, 2016
Declaration: A Commitment to Scientific Discovery
Monday, December 05, 2016
Remembering Dr. Harold Nitowsky
Monday, November 21, 2016
New Script Center Make Prescription Pick-up Easy
Friday, November 11, 2016
< Previous | Next >